Crinecerfont, a first-in-class therapy, improved androgen control and reduced reliance on high-dose glucocorticoids for patients with congenital adrenal hyperplasia.
A new study led by the Congenital Heart Initiative explores quality of life, mental health, and physical activity outcomes in a large cohort of adults with congenital heart disease.
A team of researchers sought to find the effectiveness of high spinal anesthesia and general anesthesia in postoperative recovery times among pediatric patients undergoing congenital heart surgery.
Ivacaftor appears to be safe for young children with cystic fibrosis, though elevated liver function tests may call for increased monitoring, according to research from the KIWI study group.
